Literature DB >> 15071049

Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.

Vanda Akico Ueda Fick de Souza1, Silvana Fernandes, Evaldo Stanislau Araújo, Adriana Fumie Tateno, Olímpia M N P F Oliveira, Renato Reis Oliveira, Cláudio Sérgio Pannuti.   

Abstract

An enzyme-linked immunosorbent assay-based immunoglobulin G (IgG) antibody avidity test was evaluated by using sera from 57 patients with acute dengue infection. Overall, 55 of 57 patients were correctly classified (27 of 27 with primary dengue and 28 of 30 with secondary dengue). We conclude that the IgG avidity test can be useful for differentiating between acute, primary, and secondary dengue infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15071049      PMCID: PMC387572          DOI: 10.1128/JCM.42.4.1782-1784.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study.

Authors:  M G Guzmán; G P Kouri; J Bravo; M Soler; S Vazquez; L Morier
Journal:  Am J Trop Med Hyg       Date:  1990-02       Impact factor: 2.345

2.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever.

Authors:  S C Kliks; A Nisalak; W E Brandt; L Wahl; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

Review 3.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

4.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.

Authors:  S C Kliks; S Nimmanitya; A Nisalak; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

5.  Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.

Authors:  M Paunio; K Hedman; I Davidkin; M Valle; O P Heinonen; P Leinikki; A Salmi; H Peltola
Journal:  Epidemiol Infect       Date:  2000-04       Impact factor: 2.451

6.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

7.  Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity.

Authors:  N K Blackburn; T G Besselaar; B D Schoub; K F O'Connell
Journal:  J Med Virol       Date:  1991-01       Impact factor: 2.327

8.  Measurement of avidity of specific IgG for verification of recent primary rubella.

Authors:  K Hedman; S A Rousseau
Journal:  J Med Virol       Date:  1989-04       Impact factor: 2.327

Review 9.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

10.  Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection.

Authors:  G Enders; F Knotek
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

View more
  41 in total

1.  B-cell responses during primary and secondary dengue virus infections in humans.

Authors:  Anuja Mathew; Kim West; Siripen Kalayanarooj; Robert V Gibbons; Anon Srikiatkhachorn; Sharone Green; Daniel Libraty; Smita Jaiswal; Alan L Rothman
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

3.  Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample.

Authors:  Séverine Matheus; Xavier Deparis; Bhety Labeau; Josiane Lelarge; Jacques Morvan; Philippe Dussart
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

6.  Low sensitivity of NS1 protein tests evidenced during a dengue type 2 virus outbreak in Santos, Brazil, in 2010.

Authors:  Alvina Clara Felix; Camila Malta Romano; Cristiane de Campos Centrone; Célia Lima Rodrigues; Lucy Villas-Boas; Evaldo Stanislau Araújo; Andréia Manso de Matos; Karina Inácio Carvalho; Celina Maria Turchi Martelli; Esper Georges Kallas; Claúdio Sérgio Pannuti; José Eduardo Levi
Journal:  Clin Vaccine Immunol       Date:  2012-10-24

7.  Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.

Authors:  Derek A Holmes; David E Purdy; Day-Yu Chao; Amanda J Noga; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Authors:  Harry E Prince; Mary Lapé-Nixon; Michael P Busch; Leslie H Tobler; Gregory A Foster; Susan L Stramer
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

9.  Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

10.  Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.

Authors:  S Klimashevskaya; A Obriadina; T Ulanova; G Bochkova; A Burkov; A Araujo; Susan L Stramer; Leslie H Tobler; Michael P Busch; Howard A Fields
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.